Skip to main content

Table 1 Descriptive demographic, clinical data of 63 cases of AML

From: The prognostic impact of Wilms tumor-1 polymorphism (rs16754) and human myeloid inhibitory C-type lectin-like receptor expression in cytogenetically normal-acute myeloid leukemia

Parameters

AML cases (N = 63), N (%)

Gender

Male

36 (57.1)

Female

27 (42.9)

Hepatomegaly

Normal

44 (69.8)

Enlarged

19 (30.2)

Splenomegaly

Normal

40 (63.5)

Enlarged

23 (36.5)

Lymph node

Normal

44 (69.8)

Enlarged

19 (30.2)

WHO Classification

M0

4 (6.3)

M1 (NOS)

14 (22.2)

M2 (NOS)

27 (42.9)

M4 (NOS)

3 (4.8)

M5

14 (22.2)

M7

1 (1.6)

Age (years)

Mean ± SD

47.92 ± 14.64

Hemoglobin (g/dl)

Mean ± SD

7.79 ± 1.69

TLC (Ă— 109/L)

Mean ± SD

46.51 ± 59.81

Platelets (Ă— 109/L)

Mean ± SD

69.37 ± 53.59

Blast cells (%)

Mean ± SD

59.48 ± 23.83

LDH (IU/dl)

Mean ± SD

676.11 ± 615.57

ALT (IU/dl)

Mean ± SD

31.22 ± 17.66

AST (IU/dl)

Mean ± SD

26.29 ± 12.06

Creatinine (mg/dl)

Mean ± SD

1.60 ± 1.37

BUN

Mean ± SD

31.57 ± 20.67

Survival/month

Mean ± SD

10.29 ± 7.54

  1. N number, SD standard deviation, N number, TLC total leucocytic count